light heavyweight champion Muhammed
Lawal tested positive for the steroid Drostanolone in his most
recent bout, the Nevada State Athletic Commission disclosed on
Lawal, better known by the ring name “King Mo,” scored a
second-round knockout of previously unbeaten Lorenz
Larkin at Strikeforce
“Rockhold vs. Jardine,” which took place Jan. 7 at the Hard
Rock Hotel and Casino in Las Vegas. While the win seems likely to
be overturned, NSAC Executive Director Keith Kizer says no ruling
has been made on the issue at this time.
“The matter has been referred to the Attorney General’s office for
issuance of a complaint for disciplinary action,” Kizer stated when
reached for comment by Sherdog.com.
Contacted for comment shortly after the NSAC disclosed the test
results, Lawal’s manager, Mike Kogan, repeatedly stressed that
Lawal is unfamiliar with the substance for which he reportedly
“He doesn’t even know what [Drostanolone] is,” Kogan told
Drostanolone, also known as Drolban, is an anabolic steroid popular
in the bodybuilding community and commonly used for weight-cutting.
Sold under the trade name Masteron, it is also used in the
treatment of certain forms of breast cancer.
A former NCAA Division II wrestling champion, 31-year-old Lawal has
compiled a 9-1 record in MMA after debuting in 2008 with a shocking
upset of 60-fight veteran Travis
Wiuff. The Tennessee native, who recently joined the renowned
American Kickboxing Academy, has knocked out Larkin and Roger
Gracie since dropping his Strikeforce belt to Rafael
Cavalcante in 2010.
All other fighters from the Jan. 7 Strikeforce event, including
middleweight champion Luke
Rockhold and challenger Keith
Jardine, tested negative for prohibited substances.
This item was updated at 1:41 p.m. ET to include a quote from
Lawal’s management. Mike Whitman contributed to this story.